Sarah Beck
Concepts (393)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disinfection | 14 | 2026 | 129 | 3.830 |
Why?
| | Ultraviolet Rays | 11 | 2026 | 388 | 2.680 |
Why?
| | Disinfectants | 3 | 2026 | 46 | 2.610 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 13 | 2024 | 92 | 2.570 |
Why?
| | Water Purification | 9 | 2024 | 157 | 2.530 |
Why?
| | Levivirus | 4 | 2025 | 18 | 1.670 |
Why?
| | Simian Immunodeficiency Virus | 12 | 2024 | 92 | 1.670 |
Why?
| | Virus Inactivation | 2 | 2025 | 13 | 1.110 |
Why?
| | Virus Latency | 5 | 2019 | 90 | 1.070 |
Why?
| | Macaca nemestrina | 7 | 2017 | 29 | 0.980 |
Why?
| | Disease Models, Animal | 19 | 2024 | 4569 | 0.930 |
Why?
| | Laundering | 1 | 2025 | 1 | 0.910 |
Why?
| | Textiles | 1 | 2025 | 22 | 0.880 |
Why?
| | Sodium Hypochlorite | 1 | 2024 | 5 | 0.880 |
Why?
| | Monkeypox virus | 1 | 2024 | 23 | 0.860 |
Why?
| | Macaca mulatta | 9 | 2024 | 191 | 0.860 |
Why?
| | Water Pollutants, Chemical | 2 | 2026 | 234 | 0.850 |
Why?
| | Water Microbiology | 4 | 2022 | 90 | 0.840 |
Why?
| | Escherichia coli | 6 | 2024 | 855 | 0.780 |
Why?
| | CD4-Positive T-Lymphocytes | 8 | 2020 | 1129 | 0.770 |
Why?
| | RNA, Viral | 3 | 2016 | 688 | 0.720 |
Why?
| | Virus Replication | 6 | 2019 | 529 | 0.690 |
Why?
| | AIDS Dementia Complex | 3 | 2017 | 52 | 0.680 |
Why?
| | Vascularized Composite Allotransplantation | 4 | 2023 | 30 | 0.660 |
Why?
| | Central Nervous System | 3 | 2018 | 281 | 0.660 |
Why?
| | Germinal Center | 1 | 2019 | 67 | 0.590 |
Why?
| | HIV Infections | 7 | 2020 | 3154 | 0.580 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2019 | 917 | 0.560 |
Why?
| | HIV-1 | 3 | 2019 | 896 | 0.550 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2016 | 202 | 0.520 |
Why?
| | Macrophages | 7 | 2019 | 1511 | 0.510 |
Why?
| | SAIDS Vaccines | 1 | 2016 | 4 | 0.480 |
Why?
| | Vaccines, Virus-Like Particle | 1 | 2016 | 5 | 0.480 |
Why?
| | Viral Load | 9 | 2021 | 526 | 0.470 |
Why?
| | Gene Products, gag | 1 | 2016 | 38 | 0.470 |
Why?
| | Microbial Viability | 1 | 2015 | 90 | 0.450 |
Why?
| | Anti-Retroviral Agents | 5 | 2024 | 250 | 0.440 |
Why?
| | Blood Platelets | 4 | 2024 | 400 | 0.420 |
Why?
| | Coronavirus Infections | 4 | 2021 | 378 | 0.420 |
Why?
| | DNA Damage | 2 | 2014 | 430 | 0.410 |
Why?
| | B-Lymphocytes | 1 | 2019 | 877 | 0.410 |
Why?
| | Animals | 44 | 2024 | 38109 | 0.400 |
Why?
| | Disease Susceptibility | 1 | 2015 | 348 | 0.380 |
Why?
| | Skin Transplantation | 3 | 2024 | 85 | 0.380 |
Why?
| | Adenoviridae | 1 | 2013 | 199 | 0.380 |
Why?
| | Thrombosis | 3 | 2023 | 393 | 0.360 |
Why?
| | Graft Rejection | 5 | 2023 | 540 | 0.350 |
Why?
| | Osteoma, Osteoid | 1 | 2011 | 4 | 0.350 |
Why?
| | Antiviral Agents | 1 | 2017 | 768 | 0.340 |
Why?
| | Cognitive Dysfunction | 1 | 2017 | 464 | 0.340 |
Why?
| | Thoracic Vertebrae | 1 | 2011 | 79 | 0.330 |
Why?
| | Hemostasis | 2 | 2024 | 102 | 0.320 |
Why?
| | Infarction, Middle Cerebral Artery | 2 | 2023 | 42 | 0.310 |
Why?
| | Tibia | 1 | 2011 | 176 | 0.310 |
Why?
| | Hydrogen Peroxide | 2 | 2024 | 336 | 0.300 |
Why?
| | Bone Neoplasms | 1 | 2011 | 256 | 0.280 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 2 | 2019 | 11 | 0.280 |
Why?
| | Skin | 3 | 2024 | 758 | 0.280 |
Why?
| | Water | 2 | 2022 | 469 | 0.280 |
Why?
| | Diarrhea | 2 | 2020 | 192 | 0.260 |
Why?
| | Antibodies, Viral | 2 | 2021 | 672 | 0.240 |
Why?
| | Fibromyalgia | 1 | 2026 | 52 | 0.240 |
Why?
| | Calcium Signaling | 2 | 2020 | 252 | 0.240 |
Why?
| | Sewage | 1 | 2026 | 32 | 0.230 |
Why?
| | Waste Disposal, Fluid | 1 | 2026 | 53 | 0.230 |
Why?
| | Monkey Diseases | 2 | 2016 | 25 | 0.230 |
Why?
| | Photolysis | 1 | 2026 | 94 | 0.230 |
Why?
| | Detergents | 1 | 2025 | 44 | 0.220 |
Why?
| | Pressure | 3 | 2014 | 225 | 0.220 |
Why?
| | Heart Transplantation | 2 | 2022 | 736 | 0.220 |
Why?
| | Stainless Steel | 1 | 2024 | 21 | 0.220 |
Why?
| | Glass | 1 | 2024 | 46 | 0.220 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2024 | 52 | 0.210 |
Why?
| | Neuroticism | 1 | 2024 | 16 | 0.210 |
Why?
| | Wood | 1 | 2024 | 21 | 0.210 |
Why?
| | Humans | 32 | 2026 | 144957 | 0.210 |
Why?
| | CCR5 Receptor Antagonists | 2 | 2014 | 6 | 0.210 |
Why?
| | Common Cold | 1 | 2024 | 15 | 0.210 |
Why?
| | Cyclohexanes | 2 | 2014 | 23 | 0.210 |
Why?
| | Genome-Wide Association Study | 3 | 2026 | 1407 | 0.200 |
Why?
| | Surface Properties | 1 | 2024 | 410 | 0.200 |
Why?
| | Nerve Regeneration | 1 | 2023 | 57 | 0.190 |
Why?
| | Growth Hormone | 1 | 2023 | 92 | 0.190 |
Why?
| | Neuroglia | 1 | 2024 | 172 | 0.190 |
Why?
| | Thrombocytopenia | 1 | 2024 | 205 | 0.190 |
Why?
| | Personality | 1 | 2024 | 132 | 0.190 |
Why?
| | Marijuana Abuse | 1 | 2025 | 211 | 0.190 |
Why?
| | Triazoles | 2 | 2014 | 184 | 0.180 |
Why?
| | Regeneration | 1 | 2024 | 197 | 0.180 |
Why?
| | Cation Transport Proteins | 1 | 2023 | 118 | 0.180 |
Why?
| | Organ Preservation Solutions | 1 | 2022 | 47 | 0.180 |
Why?
| | Cricetinae | 4 | 2024 | 304 | 0.180 |
Why?
| | Marijuana Use | 1 | 2025 | 213 | 0.180 |
Why?
| | Brain | 4 | 2019 | 2941 | 0.170 |
Why?
| | Myeloid Cells | 2 | 2019 | 148 | 0.170 |
Why?
| | Spinal Cord | 1 | 2024 | 382 | 0.170 |
Why?
| | Wound Healing | 1 | 2024 | 351 | 0.170 |
Why?
| | Hand Hygiene | 1 | 2020 | 9 | 0.170 |
Why?
| | Dipeptidyl Peptidase 4 | 2 | 2019 | 15 | 0.160 |
Why?
| | Myocutaneous Flap | 1 | 2020 | 8 | 0.160 |
Why?
| | Superficial Back Muscles | 1 | 2020 | 16 | 0.160 |
Why?
| | Mice | 14 | 2024 | 18365 | 0.160 |
Why?
| | Allergy and Immunology | 1 | 2020 | 42 | 0.160 |
Why?
| | Swine | 5 | 2021 | 833 | 0.160 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2015 | 341 | 0.160 |
Why?
| | Disease Progression | 2 | 2020 | 2852 | 0.150 |
Why?
| | Ethanol | 1 | 2024 | 627 | 0.150 |
Why?
| | Photoacoustic Techniques | 1 | 2019 | 5 | 0.150 |
Why?
| | Pancreas | 2 | 2019 | 342 | 0.150 |
Why?
| | Hyperthermia, Induced | 1 | 2020 | 121 | 0.150 |
Why?
| | Clinical Laboratory Techniques | 1 | 2020 | 96 | 0.150 |
Why?
| | Severity of Illness Index | 4 | 2021 | 2925 | 0.150 |
Why?
| | Immunoconjugates | 1 | 2021 | 137 | 0.150 |
Why?
| | Homeostasis | 1 | 2023 | 640 | 0.150 |
Why?
| | Recovery of Function | 1 | 2023 | 710 | 0.150 |
Why?
| | Hindlimb | 1 | 2019 | 131 | 0.140 |
Why?
| | Bacteroides fragilis | 1 | 2018 | 14 | 0.140 |
Why?
| | Mammaplasty | 1 | 2020 | 104 | 0.140 |
Why?
| | Soil | 1 | 2020 | 214 | 0.140 |
Why?
| | Genetic Predisposition to Disease | 2 | 2026 | 2365 | 0.140 |
Why?
| | Lung | 6 | 2021 | 4109 | 0.140 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2018 | 44 | 0.140 |
Why?
| | Fiducial Markers | 1 | 2018 | 9 | 0.140 |
Why?
| | Cone-Beam Computed Tomography | 1 | 2018 | 30 | 0.140 |
Why?
| | Equipment Contamination | 1 | 2018 | 71 | 0.140 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2018 | 39 | 0.140 |
Why?
| | Agriculture | 1 | 2019 | 104 | 0.140 |
Why?
| | Cross Reactions | 1 | 2018 | 130 | 0.130 |
Why?
| | Pandemics | 3 | 2021 | 1695 | 0.130 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 428 | 0.130 |
Why?
| | Th17 Cells | 1 | 2018 | 101 | 0.130 |
Why?
| | Diastole | 2 | 2015 | 143 | 0.130 |
Why?
| | Potassium Compounds | 1 | 2017 | 7 | 0.130 |
Why?
| | Atrazine | 1 | 2017 | 7 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Sulfates | 1 | 2017 | 49 | 0.130 |
Why?
| | Male | 19 | 2026 | 72406 | 0.130 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 359 | 0.120 |
Why?
| | Meningitis | 1 | 2017 | 80 | 0.120 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2018 | 365 | 0.120 |
Why?
| | Sunlight | 1 | 2017 | 78 | 0.120 |
Why?
| | Receptors, Virus | 1 | 2016 | 96 | 0.120 |
Why?
| | Syk Kinase | 1 | 2016 | 22 | 0.120 |
Why?
| | Gene Expression | 2 | 2024 | 1490 | 0.120 |
Why?
| | Encephalitis | 1 | 2017 | 142 | 0.120 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2017 | 278 | 0.120 |
Why?
| | Safety | 1 | 2018 | 356 | 0.120 |
Why?
| | Lymphocytes | 1 | 2017 | 382 | 0.120 |
Why?
| | Anti-Infective Agents | 1 | 2018 | 242 | 0.110 |
Why?
| | Arterial Occlusive Diseases | 1 | 2016 | 90 | 0.110 |
Why?
| | Colitis | 1 | 2018 | 280 | 0.110 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2016 | 131 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2024 | 2185 | 0.110 |
Why?
| | Immunotherapy | 1 | 2020 | 657 | 0.110 |
Why?
| | Immune Evasion | 1 | 2016 | 64 | 0.110 |
Why?
| | Primary Cell Culture | 1 | 2016 | 174 | 0.110 |
Why?
| | Vitamin B 12 | 1 | 2016 | 127 | 0.110 |
Why?
| | Viral Proteins | 1 | 2017 | 355 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Neurons | 1 | 2024 | 1642 | 0.110 |
Why?
| | Cryptosporidium parvum | 1 | 2014 | 13 | 0.110 |
Why?
| | Endometriosis | 1 | 2015 | 57 | 0.110 |
Why?
| | Receptor, trkB | 1 | 2015 | 36 | 0.110 |
Why?
| | Pyridones | 1 | 2016 | 199 | 0.110 |
Why?
| | Mice, Inbred C57BL | 6 | 2024 | 5997 | 0.110 |
Why?
| | Iron | 1 | 2017 | 359 | 0.110 |
Why?
| | HIV Fusion Inhibitors | 1 | 2014 | 3 | 0.110 |
Why?
| | Nanoparticles | 1 | 2020 | 520 | 0.110 |
Why?
| | Antitubercular Agents | 1 | 2016 | 216 | 0.100 |
Why?
| | Polymers | 1 | 2018 | 499 | 0.100 |
Why?
| | Ventricular Dysfunction | 1 | 2014 | 16 | 0.100 |
Why?
| | Ventricular Function | 1 | 2014 | 57 | 0.100 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 390 | 0.100 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2015 | 148 | 0.100 |
Why?
| | Neuroprotective Agents | 1 | 2015 | 143 | 0.100 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2013 | 140 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 983 | 0.100 |
Why?
| | Delivery of Health Care | 1 | 2020 | 947 | 0.100 |
Why?
| | Platelet Activation | 2 | 2024 | 104 | 0.100 |
Why?
| | Myocardial Contraction | 1 | 2015 | 298 | 0.100 |
Why?
| | Fibrinolytic Agents | 1 | 2016 | 292 | 0.100 |
Why?
| | Microglia | 1 | 2016 | 269 | 0.100 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2014 | 133 | 0.100 |
Why?
| | Nasopharyngeal Diseases | 1 | 2012 | 5 | 0.090 |
Why?
| | Sheep Diseases | 1 | 2012 | 9 | 0.090 |
Why?
| | Extracellular Vesicles | 1 | 2015 | 171 | 0.090 |
Why?
| | Alleles | 1 | 2016 | 881 | 0.090 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 676 | 0.090 |
Why?
| | Pediatrics | 1 | 2020 | 1115 | 0.090 |
Why?
| | Bacteriophages | 1 | 2014 | 111 | 0.090 |
Why?
| | Nasal Polyps | 1 | 2012 | 59 | 0.090 |
Why?
| | Mesocricetus | 2 | 2021 | 46 | 0.090 |
Why?
| | Lizards | 1 | 2012 | 46 | 0.090 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2118 | 0.090 |
Why?
| | Radiography | 2 | 2011 | 845 | 0.090 |
Why?
| | Cell Culture Techniques | 1 | 2013 | 375 | 0.080 |
Why?
| | Mice, Nude | 2 | 2024 | 688 | 0.080 |
Why?
| | Hydrogels | 1 | 2018 | 700 | 0.080 |
Why?
| | Polymerase Chain Reaction | 1 | 2013 | 1054 | 0.080 |
Why?
| | Liver | 1 | 2019 | 1888 | 0.080 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 848 | 0.080 |
Why?
| | Helicobacter Infections | 1 | 2010 | 30 | 0.080 |
Why?
| | Carcinoma | 1 | 2012 | 228 | 0.080 |
Why?
| | Rodent Diseases | 1 | 2010 | 28 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 1 | 2016 | 970 | 0.080 |
Why?
| | Mice, Inbred Strains | 1 | 2010 | 397 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 927 | 0.080 |
Why?
| | Immunoglobulin M | 2 | 2021 | 284 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2017 | 1982 | 0.070 |
Why?
| | Heart Ventricles | 1 | 2014 | 760 | 0.070 |
Why?
| | Breeding | 1 | 2008 | 63 | 0.070 |
Why?
| | Immunocompromised Host | 1 | 2010 | 201 | 0.070 |
Why?
| | Female | 13 | 2026 | 78376 | 0.070 |
Why?
| | Intervertebral Disc | 1 | 2008 | 36 | 0.070 |
Why?
| | Spinal Diseases | 1 | 2008 | 50 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2026 | 2147 | 0.070 |
Why?
| | Graft Survival | 2 | 2021 | 526 | 0.070 |
Why?
| | Mice, Knockout | 4 | 2018 | 3125 | 0.070 |
Why?
| | Dog Diseases | 1 | 2008 | 70 | 0.070 |
Why?
| | Thyroid Neoplasms | 1 | 2012 | 346 | 0.070 |
Why?
| | Spleen | 2 | 2019 | 508 | 0.060 |
Why?
| | Bacteria | 1 | 2014 | 889 | 0.060 |
Why?
| | Vaccination | 1 | 2016 | 1423 | 0.060 |
Why?
| | Biomarkers | 2 | 2015 | 4275 | 0.060 |
Why?
| | Chemokine CCL2 | 2 | 2019 | 116 | 0.060 |
Why?
| | Monocytes | 2 | 2019 | 538 | 0.060 |
Why?
| | Calcinosis | 1 | 2008 | 234 | 0.060 |
Why?
| | Immunoglobulin G | 2 | 2021 | 893 | 0.060 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3550 | 0.060 |
Why?
| | Mendelian Randomization Analysis | 1 | 2025 | 55 | 0.060 |
Why?
| | Thrombopoiesis | 1 | 2024 | 8 | 0.060 |
Why?
| | Megakaryocytes | 1 | 2024 | 34 | 0.050 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2019 | 2584 | 0.050 |
Why?
| | Platelet Factor 4 | 1 | 2024 | 36 | 0.050 |
Why?
| | Mutation | 1 | 2016 | 4099 | 0.050 |
Why?
| | TRPC6 Cation Channel | 1 | 2023 | 3 | 0.050 |
Why?
| | Phenotype | 2 | 2026 | 3164 | 0.050 |
Why?
| | Toll-Like Receptors | 1 | 2024 | 194 | 0.050 |
Why?
| | Calcium | 2 | 2023 | 1184 | 0.050 |
Why?
| | Rats, Inbred Lew | 1 | 2023 | 103 | 0.050 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2023 | 35 | 0.050 |
Why?
| | Forelimb | 1 | 2023 | 39 | 0.050 |
Why?
| | Cations | 1 | 2023 | 82 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 1217 | 0.050 |
Why?
| | Feasibility Studies | 2 | 2018 | 1095 | 0.050 |
Why?
| | Dogs | 2 | 2018 | 438 | 0.050 |
Why?
| | Magnesium | 1 | 2023 | 155 | 0.050 |
Why?
| | Platelet Aggregation | 1 | 2023 | 105 | 0.050 |
Why?
| | Multifactorial Inheritance | 1 | 2024 | 203 | 0.050 |
Why?
| | RNA, Transfer | 1 | 2024 | 144 | 0.050 |
Why?
| | Gluconates | 1 | 2022 | 4 | 0.050 |
Why?
| | Disaccharides | 1 | 2022 | 21 | 0.050 |
Why?
| | Axons | 1 | 2024 | 201 | 0.050 |
Why?
| | Dextrans | 1 | 2022 | 86 | 0.040 |
Why?
| | Acute Disease | 1 | 2024 | 1031 | 0.040 |
Why?
| | Chronic Pain | 1 | 2026 | 292 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2024 | 2609 | 0.040 |
Why?
| | Immunization, Passive | 1 | 2021 | 87 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2019 | 4155 | 0.040 |
Why?
| | Organ Preservation | 1 | 2022 | 130 | 0.040 |
Why?
| | Democratic Republic of the Congo | 1 | 2020 | 33 | 0.040 |
Why?
| | Abatacept | 1 | 2021 | 56 | 0.040 |
Why?
| | State Medicine | 1 | 2020 | 27 | 0.040 |
Why?
| | Interferon-beta | 1 | 2021 | 92 | 0.040 |
Why?
| | Magnetic Fields | 1 | 2020 | 24 | 0.040 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2020 | 29 | 0.040 |
Why?
| | Stromal Interaction Molecule 1 | 1 | 2020 | 10 | 0.040 |
Why?
| | Perfusion | 1 | 2022 | 250 | 0.040 |
Why?
| | Logistic Models | 2 | 2020 | 2119 | 0.040 |
Why?
| | CTLA-4 Antigen | 1 | 2021 | 104 | 0.040 |
Why?
| | Serologic Tests | 1 | 2020 | 53 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 139 | 0.040 |
Why?
| | Glutathione | 1 | 2022 | 375 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 130 | 0.040 |
Why?
| | Allografts | 1 | 2021 | 150 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2015 | 1718 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2020 | 334 | 0.040 |
Why?
| | Antibody Formation | 1 | 2021 | 294 | 0.040 |
Why?
| | Immunoglobulin A | 1 | 2021 | 214 | 0.040 |
Why?
| | Upper Extremity | 1 | 2021 | 112 | 0.040 |
Why?
| | United Kingdom | 1 | 2020 | 338 | 0.040 |
Why?
| | Chemokine CXCL10 | 1 | 2019 | 39 | 0.040 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2019 | 37 | 0.040 |
Why?
| | Blood Cells | 1 | 2019 | 37 | 0.040 |
Why?
| | Hepatic Veins | 1 | 2019 | 32 | 0.040 |
Why?
| | Macaca | 1 | 2019 | 65 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2010 | 1915 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 217 | 0.040 |
Why?
| | Swine, Miniature | 1 | 2019 | 89 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2020 | 137 | 0.040 |
Why?
| | Tacrolimus | 1 | 2020 | 196 | 0.040 |
Why?
| | Trinitrobenzenesulfonic Acid | 1 | 2018 | 10 | 0.040 |
Why?
| | Laparotomy | 1 | 2019 | 112 | 0.040 |
Why?
| | Tissue Donors | 1 | 2022 | 424 | 0.040 |
Why?
| | Ischemia | 1 | 2022 | 421 | 0.040 |
Why?
| | Lasers | 1 | 2019 | 132 | 0.040 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2018 | 20 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 244 | 0.030 |
Why?
| | Robotics | 1 | 2019 | 87 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2021 | 1253 | 0.030 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2026 | 893 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2019 | 261 | 0.030 |
Why?
| | Interleukin-17 | 1 | 2018 | 118 | 0.030 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2024 | 683 | 0.030 |
Why?
| | Inflammation | 2 | 2020 | 2880 | 0.030 |
Why?
| | Hypersensitivity | 1 | 2020 | 252 | 0.030 |
Why?
| | Estradiol | 1 | 2021 | 533 | 0.030 |
Why?
| | Duodenum | 1 | 2018 | 77 | 0.030 |
Why?
| | Genome, Viral | 1 | 2019 | 218 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2020 | 6053 | 0.030 |
Why?
| | Feces | 1 | 2020 | 513 | 0.030 |
Why?
| | Pyrimidines | 1 | 2021 | 533 | 0.030 |
Why?
| | Pyrazinamide | 1 | 2016 | 16 | 0.030 |
Why?
| | Child | 2 | 2020 | 22657 | 0.030 |
Why?
| | Virus Internalization | 1 | 2016 | 65 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2018 | 229 | 0.030 |
Why?
| | Lymphocyte Depletion | 1 | 2016 | 132 | 0.030 |
Why?
| | Depression | 1 | 2026 | 1559 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2016 | 251 | 0.030 |
Why?
| | Rifampin | 1 | 2016 | 82 | 0.030 |
Why?
| | Transgenes | 1 | 2016 | 190 | 0.030 |
Why?
| | Isoniazid | 1 | 2016 | 71 | 0.030 |
Why?
| | Rural Population | 1 | 2020 | 650 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1077 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2017 | 561 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 583 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2020 | 847 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 2114 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1172 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2016 | 199 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2018 | 863 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 781 | 0.030 |
Why?
| | Rats | 1 | 2023 | 5614 | 0.030 |
Why?
| | Species Specificity | 1 | 2016 | 574 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1660 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 798 | 0.030 |
Why?
| | Receptors, CCR5 | 1 | 2014 | 60 | 0.030 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 289 | 0.030 |
Why?
| | Nerve Fibers | 1 | 2014 | 104 | 0.030 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2014 | 125 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2016 | 371 | 0.020 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 65 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 1048 | 0.020 |
Why?
| | Administration, Oral | 1 | 2016 | 848 | 0.020 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 338 | 0.020 |
Why?
| | Epidermis | 1 | 2014 | 157 | 0.020 |
Why?
| | Echocardiography, Doppler | 1 | 2014 | 115 | 0.020 |
Why?
| | Cytokines | 1 | 2021 | 2065 | 0.020 |
Why?
| | Cornea | 1 | 2014 | 155 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1890 | 0.020 |
Why?
| | Animals, Zoo | 1 | 2012 | 15 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3415 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1258 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2015 | 1311 | 0.020 |
Why?
| | Ligands | 1 | 2014 | 674 | 0.020 |
Why?
| | Plasma | 1 | 2013 | 225 | 0.020 |
Why?
| | Thyroxine | 1 | 2012 | 64 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2032 | 0.020 |
Why?
| | Hypothyroidism | 1 | 2012 | 67 | 0.020 |
Why?
| | Receptors, Cell Surface | 1 | 2013 | 377 | 0.020 |
Why?
| | Hyperplasia | 1 | 2012 | 174 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 851 | 0.020 |
Why?
| | Thyroid Gland | 1 | 2012 | 88 | 0.020 |
Why?
| | Signal Transduction | 2 | 2016 | 5233 | 0.020 |
Why?
| | Motor Activity | 1 | 2016 | 722 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2012 | 307 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1835 | 0.020 |
Why?
| | Helicobacter | 1 | 2010 | 3 | 0.020 |
Why?
| | Antigens, CD | 1 | 2013 | 555 | 0.020 |
Why?
| | Omeprazole | 1 | 2010 | 8 | 0.020 |
Why?
| | Clarithromycin | 1 | 2010 | 25 | 0.020 |
Why?
| | Metronidazole | 1 | 2010 | 20 | 0.020 |
Why?
| | Complement Factor D | 1 | 2010 | 28 | 0.020 |
Why?
| | Antigens, CD1 | 1 | 2010 | 60 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 1046 | 0.020 |
Why?
| | Amoxicillin | 1 | 2010 | 35 | 0.020 |
Why?
| | Sheep | 1 | 2012 | 880 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1786 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1813 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1121 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2014 | 556 | 0.020 |
Why?
| | Drug Combinations | 1 | 2010 | 392 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 7997 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3608 | 0.020 |
Why?
| | Child, Preschool | 1 | 2020 | 11799 | 0.010 |
Why?
| | Risk Factors | 1 | 2019 | 10792 | 0.010 |
Why?
| | Time Factors | 1 | 2016 | 7183 | 0.010 |
Why?
| | Aged | 1 | 2024 | 25947 | 0.010 |
Why?
| | Incidence | 1 | 2008 | 2883 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 11695 | 0.010 |
Why?
| | Age Factors | 1 | 2008 | 3335 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2008 | 2947 | 0.010 |
Why?
| | Adult | 1 | 2020 | 40506 | 0.010 |
Why?
|
|
Beck's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|